US 7582430
Immunoliposome-nucleic acid amplification (ILNAA) assay
granted A61KA61K9/127
Quick answer
US patent 7582430 (Immunoliposome-nucleic acid amplification (ILNAA) assay) held by The United States of America as represented by the Secretary of the Army expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K9/127